# CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer

> **NCT02037464** · PHASE2 · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Capsaicin Supplement (Cayenne by Nature's Way)

## Key facts

- **NCT ID:** NCT02037464
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2016-06
- **Final completion:** 2018-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02037464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02037464, "CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02037464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*